Kettering Health says it now offers TMS for depression, using magnetic fields aimed at targeted brain areas after unsuccessful antidepressant trials.
TMS added as a depression treatment option
According to Kettering Health, it now offers transcranial magnetic stimulation, or TMS, as a treatment option for depression. The April 9, 2026, source article describes TMS as a treatment that uses magnetic fields to adjust activity in targeted areas of the brain.
The source says the area most commonly targeted is the dorsolateral prefrontal cortex. It also says an MRI is used to locate the treatment area before treatment.
Who may be considered
Kettering Health states that patients must have tried two different antidepressants from two separate classes without success to be candidates for TMS. The source presents this treatment history as a requirement for candidacy.
The article does not describe every step in an evaluation, how long a full treatment course lasts, or whether all people meeting that antidepressant-history requirement will receive TMS.
What the source says about sessions
According to Kettering Health, TMS sessions last minutes rather than hours. The source also notes that follow-up care may be needed.
The article describes magnetic fields being used to adjust brain activity in selected areas. It does not provide further details in the extract about session scheduling, the number of sessions, or the form of follow-up care that may be used.
Depression context
Kettering Health cites the National Alliance on Mental Illness in stating that about 15% of U.S. adults experience major depressive disorder. The source frames TMS as one treatment option for depression for people who meet its stated antidepressant-trial requirement.
The extract does not report treatment outcomes, insurance coverage, costs, or availability beyond Kettering Health’s statement that it now offers TMS.
What this means for Ohio patients
For people looking for treatment locally, the directory lists 91 published clinics in Ohio. Kettering Health’s article describes TMS as a depression treatment option with stated eligibility requirements and MRI-based targeting.
This is general information, not medical advice.
More Ohio reporting on treatment updates.
This report is educational and is not medical advice. Coverage, availability and eligibility can change; verify details with the named source or your care team.